This retracts the article “Sacubitril/Valsartan Therapy for 14 Months Induces a Marked Improvement of Global Longitudinal Strain in Patients With Chronic Heart Failure: A Retrospective Cohort Study” by De Vecchis et al, published in Vol. 10, No. 5, 2019, p293-302, doi: https://doi.org/10.14740/cr910 [1].
After this article was published, concerns were raised about potential redundancy concerning a previous publication [2] from the same authorship group.
An investigation was conducted by the Editorial Office, and we confirmed a significant overlap between the two publications in parts of abstract, material and methods, results, and conclusions. The figures were almost the same. As a result, the Editorial Office considers this publication [1] to be redundant and has decided to retract it.
References
- 1.De Vecchis R, Paccone A, Di Maio M. Sacubitril/Valsartan therapy for 14 months induces a marked improvement of global longitudinal strain in patients with chronic heart failure: a retrospective cohort study. Cardiol Res. 2019;10(5):293–302. doi: 10.14740/cr910. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.De Vecchis R, Paccone A, Di Maio M. In heart failure with reduced ejection fraction patients' left ventricular global longitudinal strain is enhanced after 1-year therapy with sacubitril/valsartan compared with conventional therapy with angiotensin-converting enzyme-inhibitors or AT1 blockers: results from a retrospective cohort study. J Cardiovasc Med (Hagerstown) 2019;20(12):857–858. doi: 10.2459/JCM.0000000000000851. [DOI] [PubMed] [Google Scholar]